The opioid-exposed newborn: assessment and pharmacologic management
- PMID: 19344048
- PMCID: PMC2729086
The opioid-exposed newborn: assessment and pharmacologic management
Abstract
The infant exposed to opioids in utero frequently presents a challenge to the neonatal care provider in the assessment and treatment of symptoms of Neonatal Abstinence Syndrome (NAS) after birth. This review is intended to provide the healthcare professional with a brief review of current evidence and practical guidelines for optimal evaluation and pharmacologic management of the opioid-exposed newborn.
References
-
- National Institutes on Drug Abuse, National Pregnancy and Health Survey. Drug use during pregnancy. NIDA Notes. 2005. Jan/Feb,
-
- Collins G, McAllister M. Combating abuse and diversion of prescription opiate medications. Psych Annals Online. 2006;36:410–416.
-
- U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Emergency Department Trends form the Drug Abuse Warning Network, Final Estimates 1995–2002. 2003.
-
- U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS), 2003. 2003.
-
- Gottheil E, Sterling R, Weinstein S. Diminished illicit drug use as a consequence of long-term methadone maintenance. J Addict Dis. 1993;12:45–57. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical